RXI Pharma (RXII) Tops Q2 EPS by 4c

RXI Pharma (NASDAQ: RXII) reported Q2 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on RXI Pharma (RXII) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'
• Robinhood shares climb on summit momentum and analyst support